Our study suggested that the balance between vasodilator and vasoconstrictor metabolites of arachidonic acid is disturbed in obesity and is regulated by increased TRPC5 and activated cPLA2. The gene discussed is PLA2G4A; the disease is obesity due to melanocortin 4 receptor deficiency.